Results 101 to 110 of about 315 (123)
Some of the next articles are maybe not open access.
Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population
Breast Cancer, 2021The Short-Form Six-Dimension version 2 (SF-6Dv2) is the newest preference-based instrument for estimation of quality adjusted life-years (QALYs). The aim of this study is to evaluate the validity and reliability of the SF-6Dv2 in an Iranian breast cancer population.The SF-6Dv2 and FACT-B instruments were completed for 416 patients who were recruited ...
Azin, Nahvijou +2 more
openaire +2 more sources
Eliciting SF-6Dv2 health state utilities using an anchored best-worst scaling technique
Social Science & Medicine, 2021There is an increasing interest in using ordinal data collection methods, such as the best-worst scaling (BWS), to develop preference-based tariffs (value sets) for health-related quality of life instruments, yet the evidence on their performance is limited.
Ahmed M.Y. Osman +3 more
openaire +2 more sources
Mapping the cancer-specific FACT-B onto the generic SF-6Dv2
Breast Cancer, 2020The health-related quality of life (HRQoL) data extracted from cancer-specific questionnaires are often non-preference based, while patient preference-based utility data are required for health economic evaluation. This study aimed to map Functional Assessment of Cancer Therapy-Breast (FACT-B) subscales onto the Short Form six Dimension as an ...
Azin, Nahvijou +5 more
openaire +2 more sources
SF‐6Dv2 preference value set for health utility in food allergy
Allergy, 2020AbstractBackgroundThe lack of a value set allowing the calculation of QALY is an important limitation when establishing the value of emerging therapies to treat food allergy. The aim of this study was to develop a Short‐Form Six‐Dimension version 2 (SF‐6Dv2) preference value set for the calculation of health utility from the Canadian food‐allergic ...
Élise Dufresne +6 more
openaire +2 more sources
Exploring the consistency of the SF-6Dv2 in a breast cancer population
Expert Review of Pharmacoeconomics & Outcomes Research, 2020Background: Short-Form Six-Dimension version 2 (SF-6Dv2) is a multi-attribute utility instrument that can be used in combination with the SF-36v2 (SF-6Dv2SF-36) or as an independent instrument in two forms: six questions (SF-6Dv2ind-6) and 10 questions (SF-6Dv2ind-10).
Hosein Ameri +2 more
openaire +2 more sources
The European Journal of Health Economics, 2023
To explore the comparative performance and develop the mapping algorithms between EQ-5D-5L and SF-6Dv2 in China.Respondents recruited from the Chinese general population completed both EQ-5D-5L and SF-6Dv2 during face-to-face interviews. Ceiling/floor effects were reported.
Shitong Xie, Jing Wu, Gang Chen
openaire +2 more sources
To explore the comparative performance and develop the mapping algorithms between EQ-5D-5L and SF-6Dv2 in China.Respondents recruited from the Chinese general population completed both EQ-5D-5L and SF-6Dv2 during face-to-face interviews. Ceiling/floor effects were reported.
Shitong Xie, Jing Wu, Gang Chen
openaire +2 more sources
Quebec Health-related Quality of Life Population Norms in Adults Using the SF-6Dv2
Medical Care, 2022Objective: The Short-Form 6-Dimension version 2 (SF-6Dv2) is the newest version of the Short-Form 6-Dimension (SF-6D) that is widely used to calculate quality-adjusted life-years (QALYs). The aim of this study was to produce Quebec population norms from the SF-6Dv2.
Thomas G, Poder, Nathalie, Carrier
openaire +2 more sources
Comparison of four approaches in eliciting health state utilities with SF-6Dv2
The European Journal of Health EconomicsTo empirically compare four preference elicitation approaches, the discrete choice experiment with time (DCETTO), the Best-Worst Scaling with time (BWSTTO), DCETTO with BWSTTO (DCEBWS), and the Standard Gamble (SG) method, in valuing health states using the SF-6Dv2.A representative sample of the general population in Quebec, Canada, completed 6 SG ...
Hosein Ameri, Thomas G. Poder
openaire +2 more sources
2023
AbstractBackgroundHypertrophic obstructive cardiomyopathy (HOCM) is a serious and complex chronic disease severely affecting patients’ daily lives and health-related quality of life (HRQoL). The psychometric performance of generic preference-based instruments has not been compared in Chinese patients with HOCM.
Xiaoyu Wang +4 more
openaire +1 more source
AbstractBackgroundHypertrophic obstructive cardiomyopathy (HOCM) is a serious and complex chronic disease severely affecting patients’ daily lives and health-related quality of life (HRQoL). The psychometric performance of generic preference-based instruments has not been compared in Chinese patients with HOCM.
Xiaoyu Wang +4 more
openaire +1 more source
Quality-Adjusted Life Expectancy Norms Based on the EQ-5D-5L and SF-6Dv2 for China
Applied Health Economics and Health PolicyQuality-adjusted life expectancy (QALE) norms reflect the normative profiles or reference data of QALE of the general population and provide a meaningful anchor for comparison to inform healthcare decision-making. This study aimed to develop the QALE norms for the Chinese population by using a representative dataset of health utility values collected ...
Shitong Xie +3 more
openaire +2 more sources